机构

• 上海药物研究所 [23]
• 自动化研究所 [1]
• 半导体研究所 [1]

采集方式

• OAI收割 [25]

内容类型

• 期刊论文 [24]
• 会议论文 [1]

发表日期

• 2024 [2]
• 2023 [3]
• 2022 [1]
• 2021 [2]
• 2020 [5]
• 2019 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共25条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma 期刊论文  OAI收割 HAEMATOLOGICA, 2024, 卷号: 109, 期号: 4, 页码: 1206-1219 作者:  Chen, Gege;  Gao, Xuejie;  Jia, Xinyan;  Wang, Yingcong;  Xu, Li   |  收藏  |  浏览/下载：25/0  |  提交时间：2024/05/07 A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 卷号: 127, 页码: 14 作者:  Zhang, Hui;  Hu, Ke;  Lu, Yumeng;  Xu, Zhijian;  Chen, Gege   |  收藏  |  浏览/下载：33/0  |  提交时间：2024/03/25 Multiple myeloma  M1 macrophages  Th1 cells  Immunomodulatory   Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation 期刊论文  OAI收割 ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 卷号: 55, 期号: 12, 页码: 1884-1891 作者:  Jin, Shuhan;  Li, Bo;  Zhang, Bibo;  Gao, Xuejie;  Jia, Xinyan   |  收藏  |  浏览/下载：33/0  |  提交时间：2024/02/27 dihydrocelastrol  multiple myeloma  JAK2/STAT3  PSMB5  bortezomib resistance   The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway 期刊论文  OAI收割 JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 17 作者:  Wang, Yingcong;  Dong, Sanfeng;  Hu, Ke;  Xu, Li;  Feng, Qilin   |  收藏  |  浏览/下载：36/0  |  提交时间：2024/01/26 Norcantharidin  Derivative  DCZ5417  TRIP13  Anti-myeloma  MAPK   Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma 期刊论文  OAI收割 LEUKEMIA, 2023, 页码: 4 作者:  Xu, Li;  Wang, Yingcong;  Wang, Guanli;  Guo, Shushan;  Yu, Dandan   |  收藏  |  浏览/下载：40/0  |  提交时间：2023/10/17 Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma 期刊论文  OAI收割 Journal of Biomedical Science, 2022, 卷号: 29, 期号: 1 作者:  Xie,Yongsheng;  Wang,Yingcong;  Xu,Zhijian;  Lu,Yumeng;  Song,Dongliang   |  收藏  |  浏览/下载：46/0  |  提交时间：2022/06/15 4-Hydroxysalicylanilid  Ribonucleotide reductase  Deoxyribonucleotides  DNA damage repair  Multiple myeloma   Optimizing spatial properties of a new checkerboard-like visual stimulus for user-friendly SSVEP-based BCIs 期刊论文  OAI收割 JOURNAL OF NEURAL ENGINEERING, 2021, 卷号: 18, 期号: 5, 页码: 56046 作者:  Ming, Gege;   Pei, Weihua;   Chen, Hongda;   Gao, Xiaorong;   Wang, Yijun   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/05/18 Information Bottleneck Disentanglement for Identity Swapping 会议论文  OAI收割 线上, 2021.6.19 作者:  Gao, Gege;  Huang, Huaibo;  Fu, Chaoyou;  Li, Zhaoyang;  He, Ran   |  收藏  |  浏览/下载：16/0  |  提交时间：2022/06/15 A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe 期刊论文  OAI收割 Journal of Experimental & Clinical Cancer Research, 2020, 卷号: 39, 期号: 1 作者:  Hu,Liangning;  Li,Bo;  Chen,Gege;  Song,Dongliang   |  收藏  |  浏览/下载：52/0  |  提交时间：2020/07/01 Multiple myeloma  Drug-resistance  DNA damage response  Cell cycle   A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib 期刊论文  OAI收割 CANCER LETTERS, 2020, 卷号: 478, 页码: 45-55 作者:  Chen, Gege;  Hu, Ke;  Sun, Haiguo;  Zhou, Jinfeng;  Song, Dongliang   |  收藏  |  浏览/下载：41/0  |  提交时间：2020/07/01 Multiple myeloma  Bone marrow microenvironment  DNA damage  JAK2/STAT3 pathway